Generation of adaptive immune responses following influenza virus challenge is not compromised by pre-treatment with the TLR-2 agonist Pam2Cys

Por Edin Jessica Mifsud, Amabel Chern-Lyn Tan, Lorena Elizabeth Brown, Brendon Yew Loong Chua, David C. Jackson
Publicado em 2015-06-01